⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28033794 | 0.75 | — | — | |
| SCHEMBL22081743 | 0.75 | — | — | |
| SCHEMBL1031070 | 0.73 | — | — | |
| SCHEMBL27685993 | 0.73 | — | — | |
| SCHEMBL6349189 | 0.73 | — | — | |
| SCHEMBL27705009 | 0.73 | — | — | |
| SCHEMBL6007710 | 0.73 | — | — | |
| SCHEMBL14012404 | 0.71 | — | — | |
| SCHEMBL1708125 | 0.71 | — | — | |
| SCHEMBL1031676 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025262036-A1 | METHOD OF MANUFACTURING A PHARMACEUTICAL COMPOSITION | RNASSIST LTD (GB) | 2025-12-26 | — | — | WO | disclosed |
| CN-118369317-A | Melanocortin 4 receptor antagonists and uses thereof | 辉瑞大药厂 | 2024-07-19 | — | — | CN | disclosed |
| EP-4373577-A1 | ACTRII PROTEINS AND USES THEREOF | Acceleron Pharma Inc. (US) | 2024-05-29 | — | — | EP | disclosed |
| WO-2024054985-A2 | METHODS OF ADMINISTERING AN ACTIVIN TYPE IIB VARIANT | KEROS THERAPEUTICS, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| EP-3827241-B1 | DISSOCIATION OF BIOLOGICAL SAMPLES | GOLDSBOROUGH ANDREW SIMON (FR) | 2024-03-13 | — | — | EP | disclosed |
| US-20240027309-A1 | SIMPLE FIXATION AND STABILISATION | RNASSIST LTD (GB) | 2024-01-25 | — | — | US | disclosed |
| EP-4274600-A1 | COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION | Acceleron Pharma Inc. (US) | 2023-11-15 | — | — | EP | disclosed |
| US-20230220313-A1 | COMPOSITION AND METHOD FOR INACTIVATING A VIRUS | RNASSIST LTD. (GB) | 2023-07-13 | — | — | US | disclosed |
| EP-4168037-A1 | ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) | Acceleron Pharma Inc. (US) | 2023-04-26 | — | — | EP | disclosed |
| EP-4142769-A1 | ACTRII PROTEINS AND USE IN TREATING POST-CAPILLARY PULMONARY HYPERTENSION | Acceleron Pharma Inc. (US) | 2023-03-08 | — | — | EP | disclosed |
| US-20140295404-A1 | SAMPLE FIXATION AND STABILISATION | RNASSIST LTD. (GB) | 2014-10-02 | — | — | US | disclosed |
| WO-2014131906-A1 | SAMPLE FIXATION AND STABILISATION | GOLDSBOROUGH ANDREW SIMON (FR) | 2014-09-04 | — | — | WO | disclosed |
| US-20050080113-A1 | Medicinal compositions | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-04-14 | — | — | US | disclosed |
| US-6710060-B2 | 4-hydroxypiperidine derivatives having antiarrhythmic activity | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-23 | — | — | US | disclosed |
| EP-1268474-A2 | SUBSTITUTED 1,3-THIAZOLE COMPOUNDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 2003-01-02 | — | — | EP | disclosed |
| US-20020188006-A1 | 4-hydroxypiperidine derivatives having antiarrhythmic activity | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2002-12-12 | — | — | US | disclosed |
| EP-1182192-A1 | 4-HYDROXYPIPERIDINE DERIVATIVES HAVING ANTIARRHYTHMIC EFFECT | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2002-02-27 | — | — | EP | disclosed |
| WO-2001074811-A2 | SUBSTITUTED 1,3-THIAZOLE COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-10-11 | — | — | WO | disclosed |
| EP-0383128-B1 | PROCESS FOR THE FLUORINATION OF ACRYLIC ACID AND DERIVATIVES THEREOF, AND FLUORINATED ESTERS OF 2,3-DIFLUOROPROPIONIC ACID | BAYER AG (DE) | 1993-03-31 | — | — | EP | disclosed |
| US-5072030-A | PROCESS FOR THE FLUORINATION OF ACRYLIC ACID AND DERIVATIVES THEREOF AND NOVEL FLUORINATED ESTERS OF 2,3-DIFLUOROPROPIONIC ACID | BAYER AKTIENGESELLSCHAFT (DE) | 1991-12-10 | — | — | US | disclosed |